Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: scientific committees of the European Medicines Agency | Statement: [COMP, partOf, scientific committees of the European Medicines Agency]

Target entity: scientific committees of the European Medicines Agency
Context triple: [COMP, partOf, scientific committees of the European Medicines Agency]

• A. Committee for Medicinal Products for Human Use
  The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
• B. European medicines regulatory authorities
  European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
• C. European Medicines Agency
  The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
• D. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• E. Management Board of the European Medicines Agency
  The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: scientific committees of the European Medicines Agency
Triple: [COMP, partOf, scientific committees of the European Medicines Agency]

The scientific committees of the European Medicines Agency are expert panels that evaluate and provide independent scientific opinions on the quality, safety, and efficacy of medicines for human and veterinary use in the European Union.

Target entity: scientific committees of the European Medicines Agency
Target entity description: The scientific committees of the European Medicines Agency are expert panels that evaluate and provide independent scientific opinions on the quality, safety, and efficacy of medicines for human and veterinary use in the European Union.

• A. Committee for Medicinal Products for Human Use
  The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
• B. European medicines regulatory authorities
  European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
• C. European Medicines Agency chosen
  The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
• D. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• E. Management Board of the European Medicines Agency
  The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
• F. None of above.